What evidence is currently available regarding the use of genicular artery embolization (GAE) for treating knee osteoarthritis? Principal investigator Dr. Mark Little discusses the GENESIS 2 trial, a large randomized controlled study aimed at assessing the outcomes of embolizing abnormal genicular arteries to reduce pain in patients with mild to moderate knee osteoarthritis.

Dr. Little explains the trial’s design, methodology, and the significance of key data points such as the Knee Injury and Osteoarthritis Outcome Score (KOOS), cost-effectiveness, and quality of life measures. He also covers the materials and techniques used in both the GENESIS 1 and 2 trials, the neuropsychological tests integrated into the study, and potential geographic and anatomical challenges encountered during GAE. Dr. Little highlights the importance of high-quality research and data to support the procedure's efficacy and safety.

TIMESTAMPS

00:00 - Overview of GENESIS 2 Trial

04:42 - Embolic Materials and Techniques

09:10 - Challenges in Patient Anatomy & Comorbidities

12:40 - Final Thoughts

CHECK OUT THE FULL EPISODE

Exploring GAE: Clinical Insights & Outcomes with Dr. Mark Little

https://www.backtable.com/shows/msk/podcasts/50/exploring-gae-clinical-insights-outcomes